Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as ...
Tacoma police won’t prioritize arrests of those who use plant psychedelics, city decides
Moving forward Tacoma police will not prioritize investigating, arresting and prosecuting anyone who engages in ...
Marijuana Moment4d
Washington’s Third Largest City Deprioritizes Psychedelics Enforcement, Calls For Statewide Decriminalization
Leaders in Washington State’s third largest city have unanimously approved a resolution to deprioritize local enforcement of ...